# RETRACTION: Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal

**Authors:** Journal of Oncology

PMC · DOI: 10.1155/jo/9832873 · Journal of Oncology · 2025-11-14

## Full-text entities

- **Genes:** PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** Osteosarcoma (MESH:D012516), Cancer (MESH:D009369)
- **Chemicals:** Chelerythrine (MESH:C016299)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12638130/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12638130/full.md

---
Source: https://tomesphere.com/paper/PMC12638130